Switch to:
More From Other Websites
Better Buy: AbbVie Inc. vs. Pfizer Apr 22 2017
Cramer's lightning round: This drug stock is simply not good enough for your portfolio Apr 21 2017
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug Apr 21 2017
What's in Store for AbbVie (ABBV) this Earnings Season? Apr 21 2017
Blog Coverage AbbVie's HCV Regimen Achieves 99% Cure Rate in Phase III Study Apr 21 2017
AbbVie to Present at the Deutsche Bank 42nd Annual Health Care Conference Apr 21 2017
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of... Apr 21 2017
AbbVie, Inc. – Value Analysis (NYSE:ABBV) : April 20, 2017 Apr 20 2017
Failure Of Abbvie's Cancer Drug Hasn't Hurt The Stock Apr 20 2017
AbbVie's PARP Inhibitor Comes Up Empty Apr 20 2017
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies Apr 20 2017
AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P)... Apr 20 2017
AbbVie cancer drug fails two late-stage trials Apr 19 2017
AbbVie, Inc. breached its 50 day moving average in a Bearish Manner : ABBV-US : April 19, 2017 Apr 19 2017
Top 4 Medicinal Marijuana Stocks to Watch for 2017 Apr 19 2017
Dow's Johnson & Johnson Highlights 'Multiple Issues' For Drugs, Biotechs Apr 18 2017
Is AbbVie a Great Dividend Stock for Your Portfolio? Apr 18 2017
The Better Big Pharma Stock: AbbVie or Gilead? Apr 18 2017
High-Yield Healthcare Investments You Can Buy Right Now Apr 18 2017
Can Lilly Survive Rheumatoid Arthritis Flop With Breast Cancer Drug? Apr 17 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK